FDA Approved: TIROSINT — Supplemental Application (IBSA Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for TIROSINT (levothyroxine sodium) from IBSA Pharma Inc., updating labeling as part of the supplemental approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Goiter
• Hypothyroidism

Drugs mentioned

• TIROSINT (Levothyroxine Sodium)

Snippet

SUPPL AP for TIROSINT (LEVOTHYROXINE SODIUM)